UBS assumes neutral on Revvity, raises price target to $140
UBS coverage on Revvity is assumed at a neutral rating versus a previous buy, with the price target raised to $140.00 per share from $120.00.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.